A new study has revealed significant racial disparities in how quickly minorities with the most common form of lung cancer receive potentially lifesaving radiation therapy compared with their white counterparts.
A new immunotherapy from China may offer another option for post-chemoradiotherapy treatment in patients with unresectable with stage III non-small cell lung cancer.